covid-19
Oxford-AstraZeneca vaccine 70% effective, Lancet review shows
Britain begins inoculating its population against Covid-19 using a vaccine developed by Pfizer and BioNTech
08 December 2020 - 22:56
A vaccine developed by the University of Oxford and AstraZeneca provided protection against severe Covid-19, a peer-reviewed study found, though more analysis will be needed to see how well it works in older people, among those at highest risk in the pandemic.
Trial results published on Tuesday in The Lancet medical journal suggest that the shot prevents the worst symptoms. Yet the vaccine’s efficacy couldn’t be assessed in older age groups, the data show...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.